US drug manufacturers may settle pricing battle with pharmacists

被引：0
|
作者：
Barnett, AA
机构：
来源：
LANCET | 1996年 / 347卷 / 8996期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：255 / 255
页数：1
相关论文
共 50 条
  • [1] DIFFERENTIAL PRICING BY DRUG MANUFACTURERS
    PAXINOS, J
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1975, 32 (08): : 783 - 783
  • [2] GENERIC DRUG MANUFACTURERS LOSE PATENT PROTECTION BATTLE
    MCGOURTY, C
    [J]. NATURE, 1988, 335 (6193) : 756 - 756
  • [3] Product monographs supplied by drug manufacturers to community pharmacists in Spain
    Fernández-Llimós, F
    Loza, MI
    [J]. ANNALS OF PHARMACOTHERAPY, 2000, 34 (03) : 407 - 407
  • [4] Number of Manufacturers and Generic Drug Pricing From 2005 to 2017
    Hernandez, Inmaculada
    Good, Chester B.
    Gellad, Walid F.
    Parekh, Natasha
    He, Meiqi
    Shrank, William H.
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2019, 25 (07): : 348 - +
  • [5] US drug manufacturers will have to disclose payments to doctors
    Moynihan, Ray
    [J]. BRITISH MEDICAL JOURNAL, 2010, 340
  • [6] Drug Pricing for Competing Pharmaceutical Manufacturers Distributing through a Common PBM
    Kouvelis, Panos
    Xiao, Yixuan
    Yang, Nan
    [J]. PRODUCTION AND OPERATIONS MANAGEMENT, 2018, 27 (08) : 1399 - 1419
  • [7] US pharmacists resist drug-information effort
    Barnett, AA
    [J]. LANCET, 1996, 347 (9010): : 1254 - 1254
  • [8] US pharmacists agree to give consumers drug information
    Barnett, AA
    [J]. LANCET, 1997, 349 (9047): : 261 - 261
  • [9] PREMIUM-PRICING STRATEGIES AND REPUTATIONAL COSTS FOR MANUFACTURERS: INCENTIVES AND CONSTRAINTS IN THE EVOLVING US PRICING AND REIMBURSEMENT ENVIRONMENT
    Enev, T.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A50 - A51
  • [10] Inflation Reduction Act and US drug pricing
    Sarpatwari, Ameet
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2022, 378
12345